|
21.06.2024 11:54:46
|
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.
| June 21, 2024 Company announcement No. 23 |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Novo Holdings A/S |
| 2. | Reason for the notification | |
| a) | Position/status | Novo Holding A/S is closely related to its CEO Kasim Kutay, who is a member of Novonesis' board of directors |
| b) | Initial notification/ Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Novozymes A/S, part of Novonesis Group |
| b) | LEI | 529900T6WNZXD2R3JW38 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument Identification code | B-Shares DK0060336014 |
| b) | Nature of the transaction | Purchase of shares |
| c) | Price(s) and volume(s) | Price: 441.5135 Volume: 7,623,830 shares |
| d) | Aggregated information
| Number of shares: 7,623,830 Average price, DKK: 441.5135 Transaction value, DKK: 3,366,023,866 |
| e) | Date of transaction | June 20, 2024 |
| f) | Place of the transaction | Outside a trading window |
| Contact information | ||
| Tobias Bjorklund +45 3077 8682 tobb@novonesis.com | ||
Anders Enevoldsen +45 5350 1453 adev@novonesis.com | ||
Disa Tuominen +45 6038 5826 ditu@novonesis.com | ||
Attachment
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novozymes A-S (B)mehr Nachrichten
|
27.08.24 |
Ausblick: Novozymes A-S (B) mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
|
13.08.24 |
Erste Schätzungen: Novozymes A-S (B) verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Novozymes A-S (B)mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.